Has Brian Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,678,073 in general payments to Brian Smith, MD across 1,040 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Smith, MD

Family Medicine · Versailles, KYNPI 1992749873

Payments from drug & device makers

$7,678,073in general payments, 2019–2025

Across 1,040 payments — averaging $7382.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$6.6M
Merck$397K
Bavarian Nordic A/s$276K
Pfizer$161K
Genentech, Inc.$109K
AstraZeneca$59K
plus $125K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	363	$6,551,898
Merck	21	$396,805
Bavarian Nordic A/s	13	$275,763
Pfizer	66	$160,937
Genentech, Inc.	45	$108,871
AstraZeneca	5	$58,796
GSK	34	$50,748
Alnylam Pharmaceuticals Inc.	101	$29,580
Bayer	37	$21,686
Johnson & Johnson	54	$13,309
Eli Lilly	1	$5,000
AbbVie(2 entities)	93	$875
Boehringer Ingelheim	26	$355
Lilly USA, LLC	17	$269
Corium, LLC	17	$233
Sanofi Pasteur Inc.	3	$212
Novo Nordisk	13	$193
Grifols USA, LLC	10	$188
Teva Pharmaceuticals USA, Inc.	6	$177
Novartis	11	$172
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$121
Axsome Therapeutics, Inc.	5	$112
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$98
Otsuka America Pharmaceutical, Inc.	5	$98
Indivior Inc.	5	$97
Sanofi-aventis U.S. LLC	5	$96
Takeda Pharmaceuticals U.S.A., Inc.	5	$83
Medicure Pharma Inc.	1	$75
Amgen	4	$74
Alkermes, Inc.	3	$72
Upsher-smith Laboratories LLC	3	$67
Arbor Pharmaceuticals, Inc.	4	$63
Abbott	4	$60
Dexcom, Inc.	4	$59
Corcept Therapeutics	3	$56
Esperion Therapeutics, Inc.	3	$48
EMD Serono, Inc.	3	$47
Seqirus USA Inc	1	$45
Ironshore Pharmaceuticals Inc.	2	$41
Almatica Pharma LLC	2	$40
Lundbeck LLC	2	$40
Mylan Specialty L.p.	1	$36
Kowa Pharmaceuticals America, Inc.	2	$31
Smith+Nephew	2	$30
Antares Pharma, Inc.	2	$28
Ipsen Biopharmaceuticals, Inc	1	$26
Ultragenyx Pharmaceutical Inc.	1	$25
Inogen, Inc.	1	$25
E.r. Squibb & Sons, L.L.C.	2	$24
Shire North American Group Inc	1	$23
Xeris Pharmaceuticals, Inc.	1	$23
Medtronic	1	$22
Neurocrine Biosciences, Inc.	1	$22
Redhill Biopharma Inc.	1	$20
Biomerieux Inc	1	$20
Verona Pharma, Inc.	1	$20
Eisai Inc.	1	$19
Gilead	1	$19
Phathom Pharmaceuticals, Inc.	1	$17
Neos Therapeutics, LP	1	$16

How this compares

$7,678,073 in reported general payments places this provider in the 95th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky →

Medicare billing

Part B allowed, 2024

$138,889

Medicare patients

469

Services billed

2,088

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Versailles

Barbara Fleming-PhillipsLexington$1.4M
Christopher RhyneLouisville$1M
Kruti PatelBurlington$463K
Michael LovelaceLouisville$244K
John RichardLexington$226K
Diego MastronardiBowling Green$196K
James TurnboPaducah$124K
Eleida Tur OlivaLexington$113K
Jeffrey GreenParis$103K
Edward SchumannFlorence$79K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →